Skip all navigation and go to page content
NN/LM Home About MAR | Contact MAR | Feedback |Site Map | Help | Bookmark and Share

Supreme Court Rules in Key Gene Patent Case

The U.S. Supreme Court on Thursday ruled against Myriad Genetics in an important gene patenting case. ┬áSummarizing the decision, the Wall Street Journal wrote, “The Supreme Court unanimously ruled Thursday that human genes isolated from the body can’t be patented, a victory for doctors and patients who argued that such patents interfere with scientific research and the practice of medicine…Justice Clarence Thomas, writing for the court, said the genes Myriad isolated are products of nature, which aren’t eligible for patents.” ┬áThe news services added, “However, the ruling wasn’t a complete loss for Myriad. The court said that DNA molecules synthesized in a laboratory were eligible for patent protection…The court adopted the position advanced by the Obama administration, which argued that isolated forms of naturally occurring DNA weren’t patentable, but artificial DNA molecules were.”

http://www.supremecourt.gov/opinions/12pdf/12-398_8njq.pdf

Leave a Reply

You must be logged in to post a comment.